We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Traditional Chinese Medicine in Cancer Care: An Overview of 5834 Randomized Controlled Trials Published in Chinese.
- Authors
Lu, Chun-Li; Li, Xun; Zhou, Hong-Mei; Zhang, Chi; Yang, Ya-Yue; Feng, Ru-Li; Long, Chao-Jun; Deng, Fang-Yuan; Li, Jing-Chun; Cao, Ze-Ming; Mao, Qi-Yuan; Zhu, Jin-Pu; Hong, Yan-Fei; Huang, Shou-Yu; Qiu, Jia-Ying; Liu, Yi-Xiu; Wang, Ying; Yan, Yu-Qian; Dong, Jia-Min; Luo, Yu-Xin
- Abstract
Background: Traditional Chinese medicine (TCM) is widely integrated into cancer care in China. An overview in 2011 identified 2384 randomized and non-randomized controlled trials (RCTs, non-RCTs) on TCM for cancer published in the Chinese literature. This article summarizes updated evidence of RCTs on TCM for cancer care. Methods: We searched 4 main Chinese databases: China National Knowledge Infrastructure, Chinese Scientific Journal Database, SinoMed, and Wanfang. RCTs on TCM used in cancer care were analyzed in this bibliometric study. Results: Of 5834 RCTs (477 157 cancer patients), only 62 RCTs were indexed in MEDLINE. The top 3 cancers treated were lung, stomach, and breast cancer. About 4752 RCTs (81.45%) tested TCM combined with conventional treatment, and 1082 RCTs (18.55%) used TCM alone for treating symptoms and side-effects. Herbal medicine was the most frequently used TCM modality (5087 RCTs; 87.20%). The most frequently reported outcome was symptom improvement (3712 RCTs; 63.63%) followed by quality of life (2725 RCTs; 46.71%), and biomarkers (2384 RCTs; 40.86%). The majority of RCTs (4051; 69.44%) concluded there were beneficial effects using either TCM alone or TCM plus conventional treatment compared with conventional treatment. Conclusion: Substantial randomized trials demonstrated different types/stages of cancer were treated by various TCM modalities, alone or in combination with conventional medicine. Further evaluation on the effects and safety of TCM modalities focusing on outcomes such as quality of life is required.
- Subjects
BIOMARKERS; PUBLISHING; BIBLIOMETRICS; RANDOMIZED controlled trials; CANCER patients; QUALITY of life; MEDLINE; CHINESE medicine; CANCER patient medical care; PATIENT safety; AUTHORSHIP
- Publication
Integrative Cancer Therapies, 2021, Vol 20, p1
- ISSN
1534-7354
- Publication type
Article
- DOI
10.1177/15347354211031650